Problems and promises of targeted therapy for Hodgkin's lymphoma.
Re
Daniel
D
The Burnham Institute, San Diego, CA, USA. dre@burnham.org
Thomas
Roman K
RK
Zander
Thomas
T
Diehl
Volker
V
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002471:Cell Transformation, Neoplastic; D020869:Gene Expression Profiling; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D006801:Humans; D011379:Prognosis; D012307:Risk Factors; D015398:Signal Transduction